Thinly traded nano cap Biomerica (NASDAQ:BMRA) rockets 114% premarket on increased volume in reaction to its announcement that
it has started shipping initial samples of its COVID-19 IgG/IgM Rapid
Test that can generate results in 10 minutes and can be performed in
non-laboratory settings.
The disposable point-of-care serology test detects
the presence of SARS-CoV-2 antibodies in a finger-stick sample and will
sell for less than $10.
The company says it has begun the application
process for Emergency Use Authorization in the U.S. and has filed a
provisional patent application with the USPTO with broad claims around
the technology used to identify several coronaviruses, including
SARS-CoV-2, SARS and MERS.
https://seekingalpha.com/news/3552890-biomerica-up-114-premarket-on-advancement-of-rapid-coronavirus-test
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.